Follicle Fuel 2
Combines dutasteride, a longer-acting 5-alpha reductase inhibitor, with oral minoxidil for patients whose physician determines it's the appropriate option.
No commitment · Cancel anytime · Physician evaluation required
Overview
Combines dutasteride, a longer-acting 5-alpha reductase inhibitor, with oral minoxidil for patients whose physician determines it's the appropriate option.
This formulation is compounded by a licensed 503A pharmacy pursuant to an individual prescription following a physician evaluation.
How It's Used
Your prescribing physician will determine the appropriate starting dose and tier based on your health history, current medications, and treatment goals. Follow your physician's specific instructions — do not adjust dose or frequency on your own.
Safety & Considerations
This medication is a 5-alpha reductase inhibitor that can cause sexual side effects (decreased libido, erectile difficulty) and has been associated with mood changes, including depression, in a subset of users — contact your provider if mood symptoms occur. This medication must not be handled by women who are or may become pregnant — tablets should not be split or crushed by anyone other than the patient, due to risk of harm to a male fetus from skin absorption. Dutasteride remains in the body for months after stopping, which is relevant to blood donation (deferral required) and to any partner who may become pregnant.
Minoxidil, taken orally, can cause fluid retention, rapid heart rate, and unwanted hair growth on areas beyond the scalp (face, body). Patients with heart conditions should be screened before use. Discontinuing minoxidil typically reverses any regrowth gained. Oral minoxidil is FDA-approved only for severe hypertension — its use for hair loss, at low doses, is off-label, though well-established in dermatology practice.
Compounded Medication Disclosure
These statements have not been evaluated by the Food and Drug Administration. This product is not FDA-approved, has not been evaluated by the FDA for safety, effectiveness, or quality, and is not represented as a generic or equivalent version of any FDA-approved drug.
References
This is a compounded, multi-ingredient formulation and, as such, has not itself been studied in dedicated clinical trials. The references below are the FDA prescribing information (or, where noted, peer-reviewed literature) for each individual active ingredient in this formulation. Ask your physician for further ingredient-specific information.
- AVODART (dutasteride) — FDA Prescribing Information
DailyMed, National Library of Medicine - Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review
MDPI Journal of Clinical Medicine, 2025